Solvay Pharma India (Delisted) share price
BSE: 532447
Solvay Pharma India Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary
Last traded ₹2,141.55 on 25 Aug 2011
Delisted on 30 Sep 2011.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
Aug 2011
11 Aug · Business
Order passed by the Hon'ble High Court of Bombay sanctioning the Scheme of Amalgamation of Solvay Pharma India Ltd. with Abbott India Ltd. ....
Jul 2011
15 Jul · Business
Hon'ble High Court of Bombay, on July 15, 2011, has sanctioned the Scheme of Amalgamation of Solvay Pharma India Limited, the Transferor ....
Jun 2011
30 Jun · Management
With reference to the earlier announcement dated March 29, 2011, regarding Mr. Niteen Gadgil had tendered his resignation as Managing Director of the Company and that he would, continue ....
May 2011
11 May · Results
Apr 2011
Results for the quarter to Mar 2011
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹81 Cr+28.9% on a year ago · +6.4% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- ₹11 Cr−0.7% on a year ago · +62.2% on the quarter before
- Net margin
- 13.9%
From revenue to net profit, ₹ crore
- Revenue81
- Other income+1.5
- One-off items−5.6
- Finance costs0.0
- Profit before tax17
- Tax−5.3
- Net profit11
Solvay Pharma India results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Mar 2011. Results for the quarter to Jun 2011 were due by 14 Aug 2011, 45 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
Peak revenue ₹84 Cr, quarter to Sep 2010; lowest ₹50 Cr, quarter to Mar 2009
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Sep 2007 | Dec 2007 | Mar 2008 | Jun 2008 | Sep 2008 | Dec 2008 | Mar 2009 | Jun 2009 | Sep 2009 | Dec 2009 | Mar 2010 | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 44.9 | 45.9 | 40.0 | 50.6 | 55.1 | 55.3 | 50.0 | 62.3 | 63.8 | 67.0 | 62.7 | 73.9 | 84.2 | 76.0 | 80.9 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | – | – | 30.9 | – | – | – | – | – | – | – | – | – | – | – | – |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 8.1 | 9.0 | 7.8 | 19.5 | 25.4 | 28.6 | 21.3 | 26.6 | 27.6 | 29.1 | 30.6 | 13.2 | 32.6 | 25.5 | 40.4 |
| Operating profit before depreciationOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary | – | – | 9.1 | – | – | – | – | – | – | – | – | – | – | – | – |
| Operating margin | – | – | 22.7% | – | – | – | – | – | – | – | – | – | – | – | – |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | – | – | 0.4 | – | – | – | – | – | – | – | – | – | – | – | – |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 0.8 | 1.4 | 1.4 | 1.3 | 0.8 | 0.8 | 0.4 | 0.4 | 1.2 | 0.3 | 0.8 | 0.8 | 1.1 | 1.1 | 1.5 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | – | 0.0 | 0.0 | 0.0 | – | 0.0 | – | – | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before one-off items and taxProfit before one-off items and tax. Profit before tax as it would be without the one-off items below it, as the company states it. Profit before one-off items and tax in the glossary | – | – | – | – | – | 10.8 | 11.7 | 16.7 | 16.5 | 15.7 | 17.0 | 23.1 | 25.7 | 10.0 | 22.2 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | −5.6 |
| Profit before tax | 13.0 | 13.5 | 10.1 | 14.4 | 14.8 | 10.8 | 11.7 | 16.7 | 16.5 | 15.7 | 17.0 | 23.1 | 25.7 | 10.0 | 16.5 |
| 4.3 | 4.7 | 3.5 | 4.8 | 5.1 | 4.0 | 4.2 | 5.9 | 5.2 | 5.3 | 5.7 | 7.7 | 8.5 | 3.1 | 5.3 | |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | 32.6% | 35.2% | 34.6% | 33.4% | 34.4% | 36.7% | 36.0% | 35.4% | 31.7% | 33.4% | 33.7% | 33.2% | 33.0% | 31.2% | 32.1% |
| Net profit | 8.8 | 8.7 | 6.6 | 9.6 | 9.7 | 6.9 | 7.5 | 10.8 | 11.2 | 10.5 | 11.3 | 15.4 | 17.2 | 6.9 | 11.2 |
| Net margin | 19.6% | 19.1% | 16.5% | 19.0% | 17.7% | 12.4% | 15.0% | 17.3% | 17.6% | 15.6% | 18.0% | 20.8% | 20.5% | 9.1% | 13.9% |
Earnings per share in rupees, restated for later splits and bonuses.
4 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to December.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
Peak revenue ₹297 Cr, year to Dec 2010; lowest ₹168 Cr, year to Dec 2007
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
Results for the year to Dec 2010
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue297
- Other income+3.7
- Finance costs0.0
- Profit before tax76
- Tax−25
- Net profit51
Profit and loss
Standalone, ₹ crore, years to December. The last column is the twelve months to Mar 2011, the latest four quarters added.
| ₹ crore | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Mar 2011Twelve months |
|---|---|---|---|---|---|
| Revenue from operations | 168 | 201 | 243 | 297 | 315 |
| – | – | – | – | – | |
| Materials and goods bought | 33 | 91 | 105 | 118 | 112 |
| Other income | 4 | 4 | 2 | 4 | 4 |
| Finance costs | 0 | 0 | 0 | 0 | 0 |
| Profit before one-off items and tax | – | 50 | 59 | 76 | 81 |
| One-off items | – | – | 1 | – | – |
| Profit before tax | 43 | 50 | 61 | 76 | 75 |
| Tax | 15 | 17 | 21 | 25 | 25 |
| Net profit | 28 | 33 | 40 | 51 | 51 |
| Net margin | 16.8% | 16.3% | 16.5% | 17.1% | 16.1% |
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Dec 2007, Dec 2008, Dec 2009 and Dec 2010: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to December.
| Ratio | Dec 2008 | Dec 2009 | Dec 2010 |
|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | 20.0% | 20.8% | 22.1% |
| Net profit growthNet profit growth. This year's net profit less last year's, divided by last year's, times 100; blank where last year's is not above nought. Net profit growth in the glossary | 16.7% | 22.0% | 27.0% |
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Dec 2010.
| Measure | 5 years | 3 years |
|---|---|---|
| Revenue growth, yearly rateRevenue growth, yearly rate. 3 years: Revenue in the latest year ÷ revenue in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Revenue in the latest year ÷ revenue in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Revenue in the latest year ÷ revenue in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | – | 21.0% |
| Profit growth, yearly rateProfit growth, yearly rate. 3 years: Profit to the company's own shareholders in the latest year ÷ profit to the company's own shareholders in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Profit to the company's own shareholders in the latest year ÷ profit to the company's own shareholders in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Profit to the company's own shareholders in the latest year ÷ profit to the company's own shareholders in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | – | 21.8% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | 16.7% | 16.6% |
Accounting checks
Standalone, years to December. Published tests of whether reported profit is backed by cash and the balance sheet.
| Check | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 |
|---|---|---|---|---|
| Effective tax ratePublished threshold 17.16 per cent | 34.46 | 34.67 | 34.01 | 32.95 |
A threshold marked as ours has no published figure; it is the line we read the check against.
Where the return came from
Yearly rates to Dec 2010, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +13.9% | – | – | 0.0% |
| 3 years | +41.5% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Recent sessions
The 10 trading days to 25 Aug 2011, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 25 Aug 2011 | 2,150.00 | 2,150.00 | 2,140.00 | 2,141.55 | – | 81 |
| 24 Aug 2011 | 2,165.00 | 2,179.00 | 2,127.80 | 2,136.35 | – | 92 |
| 23 Aug 2011 | 2,100.10 | 2,164.00 | 2,100.10 | 2,164.00 | – | 32 |
| 22 Aug 2011 | 2,120.00 | 2,153.00 | 2,107.50 | 2,149.90 | – | 62 |
| 19 Aug 2011 | 2,154.80 | 2,154.80 | 2,080.50 | 2,087.05 | – | 21 |
| 18 Aug 2011 | 2,095.25 | 2,149.90 | 2,063.00 | 2,110.30 | 2,100.94 | 391 |
| 17 Aug 2011 | 2,100.00 | 2,100.00 | 2,031.20 | 2,097.75 | 2,094.10 | 222 |
| 16 Aug 2011 | 2,098.00 | 2,098.00 | 2,052.00 | 2,054.35 | – | 54 |
| 12 Aug 2011 | 2,137.80 | 2,137.80 | 2,060.00 | 2,060.00 | 2,090.58 | 121 |
| 11 Aug 2011 | 2,099.00 | 2,125.00 | 2,085.50 | 2,100.10 | – | 46 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 532447
- ISIN
- INE593D01010
- Website
- www.solvaypharma.co.in
- Registered office
- 271 Business Park, 6th Floor, Model Industrial Colony, Off Aarey Road Goregaon (E), Mumbai 400063, Maharashtra
- Share registrar
- Link Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments